United States · FDA National Drug Code directory
Lidocaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-202_d19c26f4-1214-40f7-9680-43c885613306
- Product NDC
- 63323-202
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LIDOCAINE HYDROCHLORIDE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100527
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (63323-202-02) / 2 mL in 1 VIAL (63323-202-01) · 63323-202-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →